Reliance Chemotex Industries Ltd (RELCHEMQ)

Textiles · Textiles · NSE · Updated 16 September 2026
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
₹120.2 ↓ 26.93% (1Y)

🎯 Key Takeaways

  • Reliance Chemotex Industries Ltd is a mid-sized textile manufacturer operating in technical yarns with a focus on export-oriented production. The company exhibits characteristics of a mature, cash-generating business with stable but declining profitability, as reflected in its low ROE (4.
  • Revenue grew 12.1% QoQ to ₹99 in Q1FY27.
  • ⚠️ High debt-to-equity ratio of 1.90 poses financial risk amid low profitability and limited cash flow generation.
Market Cap
₹91
P/E Ratio
16.3
P/B Ratio
0.66
ROE
4.1%
ROCE
7.6%
Debt/Equity
1.90
Div Yield
0.42%
Promoter
67.7%

📖 The Story

Reliance Chemotex Industries Ltd is a mid-sized textile manufacturer operating in technical yarns with a focus on export-oriented production. The company exhibits characteristics of a mature, cash-generating business with stable but declining profitability, as reflected in its low ROE (4.1%) and ROCE (7.6%). Despite consistent promoter holding, its financial trajectory shows margin compression and flat growth, placing it in a stagnant or turnaround phase rather than a clear growth cycle.

📰 What's Happening

The company has recently reappointed Sanjiv Shroff as Managing Director for three years, effective September 1, 2026, ensuring leadership continuity. It has scheduled its 48th AGM for September 24, 2026, with a record date of September 18, 2026, for dividend payment and e-voting. The board approved unaudited Q1 FY27 results showing net profit of ₹136.65 lakhs, up from ₹106.33 lakhs YoY, indicating modest profit growth. However, no forward-looking guidance was provided beyond procedural disclosures. The company continues to invest in capacity expansion to strengthen its position in high-growth technical textiles markets, though specific capital allocation details remain unspecified.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

MetricSep 2025Dec 2025Mar 2026Jun 2026
Revenue100828899
Operating Profit7757
OPM %6.6%8.5%6.0%7.3%
Net Profit2121
EPS₹2.19₹1.06₹2.31₹1.81

Quarterly revenue has remained relatively stable, ranging between ₹82 crore and ₹100 crore over the last four quarters, with a slight upward trend in total income. Operating margins have declined from 8.5% in December 2025 to 6.0% in March 2026, reflecting margin pressure despite stable top-line performance. Net profit rose to ₹136.65 lakhs in Q1 FY27 from ₹106.33 lakhs in the same quarter last year, suggesting some improvement in profitability, but the company remains small-scale with limited earnings visibility. EPS has fluctuated between ₹1.06 and ₹2.31, showing inconsistency in shareholder returns.

🔮 Management Outlook & What's Next

Management has not provided explicit forward guidance on revenue, margins, or growth expectations beyond confirming the AGM date, record date for dividend, and e-voting schedule. The reappointment of the Managing Director signals stability in leadership but does not indicate a strategic shift. No commentary on future profitability, market expansion, or capital allocation beyond ongoing capacity investment was disclosed in the filings.

Extracted from official company announcements. Not StockFin.ai's opinion.

🏦 Balance Sheet (₹ Cr)

ItemMar 2025Mar 2025Mar 2026Mar 2026
Equity Capital8888
Reserves128130132135
Borrowings267261252268
Total Liabilities475474479512
Fixed Assets314311305298
Investments0200
Total Assets475474479512

The balance sheet shows a stable capital structure with equity remaining constant at ₹8 crore and reserves slightly increasing to ₹135 crore as of March 2026. Borrowings have marginally risen to ₹268 crore from ₹252 crore, indicating modest leverage growth. Total assets have grown from ₹474 crore to ₹512 crore over two years, suggesting asset base expansion, likely tied to capacity investment. The company maintains a high debt-to-equity ratio of 1.90, which raises concerns about financial risk, especially amid stagnant profitability and limited cash flow generation.

💰 Cash Flow Statement (₹ Cr)

ItemMar 2025
Operating+11
Investing+33
Financing-43
Net Cash Flow+0

👥 Shareholding Pattern

CategoryQ2FY26Q3FY26Q4FY26Q1FY27
Promoters67.7%67.7%67.7%67.7%
FII0.0%0.0%0.0%0.0%
DII0.0%0.0%0.0%0.0%
Public23.8%23.8%24.2%24.1%
# Shareholders13,13313,13313,16613,156

Promoter holding remains steady at 67.68% across all recent quarters, indicating no dilution or stake sale. Institutional ownership (FII and DII) remains negligible at 0%, while public shareholders account for approximately 24% of equity. The number of public shareholders has slightly increased, suggesting retail interest may be growing. There are no signs of institutional accumulation or significant shareholder activism, reflecting limited investor attention or confidence in near-term catalysts.

⚖️ Peer Comparison — Textiles

Company MCap (₹ Cr) P/E ROCE ROE D/E
GRASIM 2.17 L Cr 38.0 9.6% 10.8% 2.16
WELSPUNLIV 19,108 66.3 8.0% 5.8% 0.37
VTL 15,847 18.4 10.7% 8.7% 0.13
ARVIND 14,947 34.8 14.3% 10.6% 0.36
TRIDENT 11,782 29.6 10.1% 8.3% 0.37
SWANCORP 9,176 44.1 4.2% 2.9% 0.29
ICIL 8,455 56.0 9.8% 6.4% 0.46
GARFIBRES 7,672 37.0 22.9% 16.9% 0.05
KUSUMGAR 5,802 0.45
JINDWORLD 4,948 58.8 10.2% 9.8% 0.65

🔗 Peer Stock Analyses

⚠️ Risk Factors

1. High debt-to-equity ratio of 1.90 poses financial risk amid low profitability and limited cash flow generation. 2. Persistent margin compression, with operating margins declining to 6.0% in Q1 FY27 from 8.5% in December 2025, signals pricing pressure or rising input costs. 3. Lack of forward guidance from management reduces visibility into growth prospects. 4. Reliance on export markets (34.54% export revenue) exposes the company to global demand and currency volatility, which is not being actively mitigated or hedged as per disclosures.

📋 Recent Filings

🧠 Analyst's Read

Reliance Chemotex operates as a stable but stagnant textile manufacturer with modest profitability and high leverage. While leadership continuity and shareholder-friendly dividend practices are positive, the absence of growth strategy clarity and ongoing margin pressure warrant caution. Investors should monitor management’s next capital allocation decisions and any shift in strategic direction beyond incremental capacity investments.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

Sign Up Free — Unlock Full Analysis

2 free AI queries per day.

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-16.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when RELCHEMQ files new disclosures

Track RELCHEMQ filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track RELCHEMQ — Free

Free account · 2 AI queries/day